biology

Meningitis B

Meningitis B is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Meningitis B rather than just read about it. In short: Meningitis B, sometimes abbreviated as MenB, is a type of meningococcal disease caused by serotype B of the Neisseria meningitidis bacteria. Despite its name, not all meningococcal infections due to serotype B infection involve meningitis; many also cause sepsis or other complications.

Key takeaways

Meningitis B belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Meningitis B to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Meningitis B from memory before moving on to harder problems.

Reference excerpt

Meningitis B, sometimes abbreviated as MenB, is a type of meningococcal disease caused by serotype B of the Neisseria meningitidis bacteria. Despite its name, not all meningococcal infections due to serotype B infection involve meningitis; many also cause sepsis or other complications.

Epidemiology

Serogroup B is the most common cause of meningococcal disease in countries that routinely vaccinate against serotypes A, C, W, and Y. However, overall prevalence of meningococcal disease is low. From 2000 to 2015, only 2 countries had prevalence of B-MD greater than 2/100,000 with most countries reporting incidence of less than 1/100,000. The case fatality rate is high, ranging from 10%-20% even after aggressive treatment with antibiotics. Three hyper-invasive genotypes are responsible for most outbreaks. Asymptomatic carriage of serotype B bacteria in the nasopharyngneal passage is common.

MenB vaccines Vaccines against Meningococcal Group B bacteria are commonly called MenB vaccines.

There are two licensed vaccines specifically against serotype B meningococcal disease widely available; Bexsero (GSK) 4-component MenB vaccine (4CMenB) and Trumenba (Pfizer), a bivalent factor H binding protein vaccine (MenB-FHbp). In the UK and Australia, Bexsero is approved for ages 2 months to 50 years; in the UK and Australia, it is given routinely as part of childhood vaccines as infants the group at greatest risk from meningitis B. The protection offered is short and does not last past early childhood. In the US, both Bexsero and Trumenba are only approved for ages 10-25 and only given to certain high risk groups. There are additionally two pentavalent vaccines available targeting serogroups A, B, C, W, and Y: Penbraya was approved for use in the United States in October 2023. It combines the vaccines Trumenba and Nimenrix. Penbraya was authorized for medical use in the European Union in November 2024. It is approved for use in individuals 10 through 25 years of age. Penmenvy was approved for use in the United States in February 2025. Penmenvy is approved for use in people aged 10 through 25 years of age.

Vaccine development and outbreaks Historically, MenB vaccines were difficult to produce, and required a different approach from vaccines against other serotypes. Whereas effective polysaccharide vaccines have been produced against types A, C, W-135, and Y, the capsular polysaccharide on the type B bacterium is too similar to human neural adhesion molecules to be a useful target. Several "serogroup B" vaccines have been produced. Strictly speaking, these are not "serogroup B" vaccines, as they do not aim to produce antibodies to the group B antigen: it would be more accurate to describe them as serogroup-independent vaccines, as they employ different antigenic components of the organism; indeed, some of the antigens are common to different Neisseria species. A vaccine for serogroup B was developed in Cuba in response to a large outbreak of meningitis B during the 1980s. This vaccine was based on artificially produced outer membrane vesicles of the bacterium. The VA-MENGOC-BC vaccine proved safe and effective in randomized double-blind studies, but it was granted a licence only for research purposes in the United States as political differences limited cooperation between the two countries. Due to a similarly high prevalence of B-serotype meningitis in Norway between 1974 and 1988, Norwegian health authorities developed a vaccine specifically designed for Norwegian children and adolescents. Clinical trials were discontinued after the vaccine was shown to cover only slightly more than 50% of all cases. Furthermore, lawsuits for damages were filed against the State of Norway by persons affected by serious adverse reactions. Information that the health authorities obtained during the vaccine development was subsequently passed on to Chiron (now GlaxoSmithKline), who later developed a similar vaccine, MeNZB, for New Zealand.

… excerpt ends here. Continue reading the full article.

Illustrations

Meningitis B: Charlotte Cleverley-Bisman, showing necrosis (tissue death) on arms. Her case brought widespread publicity to the B-MD epidemic in New Zealand, leading to a successful vaccination campaign with MeNZB. — Charlotte Cleverley-Bisman, showing necrosis (tissue death) on arms. Her case brought widespread publicity to the B-MD epidemic in New Zealand, leading to a successful vaccination campaign with MeNZB.

Worked examples

Example 1 — a first encounter with Meningitis B

Start with the simplest possible case. Write down what Meningitis B claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Meningitis B before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Meningitis B ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Meningitis B

In research: Meningitis B appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Meningitis B in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Meningitis B is common in secondary-school and first-year university syllabi. It links to neighbouring topics Bacterial diseases, Meningitis, Sepsis, so understanding it makes those chapters shorter.
In everyday life: Look for Meningitis B outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Meningitis B in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Meningitis B means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Meningitis B out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Meningitis B in simple terms?

Why does Meningitis B matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Meningitis B?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Meningitis B.